About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ELCC 2019: European Lung Cancer Congress
AACR Annual Meeting 2019
NCCN Annual Conference 2019
2019 SGO Annual Meeting on Womens Cancer
2019 Multidisciplinary Thoracic Cancers Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
2013 Best of ASCO Chicago
Today In Oncology
DNA Rearrangement May Predict Treatment Resistance and Poor Outcomes in Multiple Myeloma
Does Squamous Cell Carcinoma Risk Change With Immunosuppression?
Does Oncotype DX–Guided Treatment Reduce Initial Costs of Breast Cancer Care?
Combined Crowd Innovation and AI in Producing Algorithms for Radiotherapy Targeting
Low-Dose Tamoxifen vs Placebo in Preventing Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
Most Read Stories
KEYNOTE-042: Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic NSCLC With PD-L1 Expression ≥ 1%
Doxepin or Diphenhydramine/Lidocaine/Antacid Mouthwash for Radiotherapy-Related Oral Mucositis Pain
Perioperative Therapy With FLOT vs ECF/ECX in Locally Advanced Gastric Adenocarcinoma
SABR-COMET: Stereotactic Ablative Radiotherapy vs Standard Palliative Treatment in Oligometastatic Cancers
Follow-up of Adjuvant Paclitaxel and Trastuzumab in Small HER2-Positive Breast Tumors
Most Viewed Videos
Ahmed Omar Kaseb, MD, on Liver Cancer: Results From an Immunotherapy Trial
Brian I. Rini, MD, on Renal Cell Cancer: Risk Stratification After Resection of Localized Disease
Heather A. Wakelee, MD, on Advanced Non–Small Cell Lung Cancer: State-of-the-Art Treatment for EGFR-Positive and ALK-Positive Diseases
Martin Edelman, MD, on Immunotherapy: How Safe Is It for Patients With Autoimmune Disease?
Melinda L. Telli, MD, on NCCN Guidelines Updates for HR-Positive, HER2-Negative Early-Stage Breast Cancer
© 2019 HSP News Service, L.L.C.